EMA Authorised: Bexsero (outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254);recombinant Neisseria meningitidis group B fHbp fusion protein;recombinant Neisseria meningitidis group B NadA protein;recombinant Neisseria meningitidis group B NHBA fusion protein) — GSK Vaccines S.r.l.

View source ↗

Summary

The European Medicines Agency authorised Bexsero, a meningococcal group B vaccine produced by GSK Vaccines S.r.l., for use in Europe. The vaccine contains multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Bexsero (Meningococcal group B vaccine (4CMenB))

Snippet

Status: Authorised. Therapeutic area: Meningitis, Meningococcal. MAH: GSK Vaccines S.r.l.. Decision date: 09/05/2024